| # | Title | Journal | Year | Citations |
|---|
| 1 | Carotenoids and human health | Pharmacological Research | 2007 | 1,530 |
| 2 | Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening | Pharmacological Research | 2005 | 1,435 |
| 3 | ERK1/2 MAP kinases: Structure, function, and regulation | Pharmacological Research | 2012 | 1,246 |
| 4 | The ErbB/HER family of protein-tyrosine kinases and cancer | Pharmacological Research | 2014 | 1,028 |
| 5 | The oral microbiome in health and disease | Pharmacological Research | 2013 | 937 |
| 6 | Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis | Pharmacological Research | 2007 | 883 |
| 7 | HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA) | Pharmacological Research | 1999 | 837 |
| 8 | The influence of diet on the gut microbiota | Pharmacological Research | 2013 | 817 |
| 9 | Targeting nanoparticles to cancer | Pharmacological Research | 2010 | 775 |
| 10 | Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and ?-cell damage in rat pancreas | Pharmacological Research | 2005 | 650 |
| 11 | The human milk microbiota: Origin and potential roles in health and disease | Pharmacological Research | 2013 | 648 |
| 12 | Oxidative stress in normal and impaired wound repair | Pharmacological Research | 2008 | 628 |
| 13 | Natural compounds for cancer treatment and prevention | Pharmacological Research | 2009 | 590 |
| 14 | Dual roles of Nrf2 in cancer | Pharmacological Research | 2008 | 586 |
| 15 | An overview on biological mechanisms of PPARs | Pharmacological Research | 2005 | 580 |
| 16 | Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes | Pharmacological Research | 2016 | 570 |
| 17 | The immune system and cardiac repair | Pharmacological Research | 2008 | 560 |
| 18 | Magnetic nanoparticles and targeted drug delivering | Pharmacological Research | 2010 | 556 |
| 19 | Interactions of gut microbiota with functional food components and nutraceuticals | Pharmacological Research | 2010 | 543 |
| 20 | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) | Pharmacological Research | 2020 | 494 |
| 21 | Cholinesterase inhibitors: new roles and therapeutic alternatives | Pharmacological Research | 2004 | 482 |
| 22 | Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review | Pharmacological Research | 2010 | 479 |
| 23 | The pharmacology of statins | Pharmacological Research | 2014 | 458 |
| 24 | Traditional Chinese medicine for COVID-19 treatment | Pharmacological Research | 2020 | 448 |
| 25 | Cisplatin resistance and opportunities for precision medicine | Pharmacological Research | 2016 | 443 |
| 26 | Obesity and hypertension | Pharmacological Research | 2017 | 430 |
| 27 | Candidate drugs against SARS-CoV-2 and COVID-19 | Pharmacological Research | 2020 | 426 |
| 28 | From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications | Pharmacological Research | 2010 | 417 |
| 29 | Kaempferol and inflammation: From chemistry to medicine | Pharmacological Research | 2015 | 417 |
| 30 | Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors | Pharmacological Research | 2015 | 416 |
| 31 | Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update | Pharmacological Research | 2020 | 415 |
| 32 | The role of protein kinase C activation and the vascular complications of diabetes | Pharmacological Research | 2007 | 409 |
| 33 | Polyunsaturated fatty acids as antioxidants | Pharmacological Research | 2008 | 397 |
| 34 | A historical overview of protein kinases and their targeted small molecule inhibitors | Pharmacological Research | 2015 | 391 |
| 35 | Prevalence and prevention of cardiovascular disease and diabetes mellitus | Pharmacological Research | 2016 | 381 |
| 36 | Properties of FDA-approved small molecule protein kinase inhibitors | Pharmacological Research | 2019 | 377 |
| 37 | CURCUMIN INHIBITION OF INFLAMMATORY CYTOKINE PRODUCTION BY HUMAN PERIPHERAL BLOOD MONOCYTES AND ALVEOLAR MACROPHAGES | Pharmacological Research | 1999 | 371 |
| 38 | The chemistry and biotransformation of tea constituents | Pharmacological Research | 2011 | 366 |
| 39 | Hypertension and cardiovascular risk: General aspects | Pharmacological Research | 2018 | 365 |
| 40 | Aescin: pharmacology, pharmacokinetics and therapeutic profile | Pharmacological Research | 2001 | 350 |
| 41 | Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications | Pharmacological Research | 2013 | 350 |
| 42 | Intestinal luminal nitrogen metabolism: Role of the gut microbiota and consequences for the host | Pharmacological Research | 2013 | 349 |
| 43 | P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement | Pharmacological Research | 2003 | 345 |
| 44 | Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions | Pharmacological Research | 2015 | 338 |
| 45 | Gender differences in drug responses | Pharmacological Research | 2007 | 336 |
| 46 | Thymoquinone and its therapeutic potentials | Pharmacological Research | 2015 | 336 |
| 47 | The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases | Pharmacological Research | 2017 | 332 |
| 48 | The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation | Pharmacological Research | 2009 | 326 |
| 49 | Intracellular signal transduction pathways activated by ceramide and its metabolites | Pharmacological Research | 2003 | 320 |
| 50 | Cellular ADMA: Regulation and action | Pharmacological Research | 2009 | 320 |
